Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 22, 2023 04:20 ET | Source: InsightAce Analytic Pvt. LTd.

Oncology Drug Discovery & Development Market Expected to Grow at a CAGR of 18.2% from 2023 to 2031 | Reveals InsightAce Study

Jersey City, NJ, Nov. 22, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oncology Drug Discovery & Development Market-...
June 22, 2020 15:00 ET | Source: Celsion CORP

Celsion Corporation Announces Pricing of $10 Million Underwritten Offering of Common Stock

Lawrenceville, NJ, June 22, 2020 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced the entry into an underwriting agreement relating to...
September 11, 2019 07:00 ET | Source: Provectus Biopharmaceuticals Inc.

Provectus Names Harold Schmitz, PhD to Company's Scientific Advisory Board

Dr. Schmitz, General Partner of The March Fund and former Chief Science Officer of Mars, Incorporated is Provectus’ inaugural Scientific Advisory Board member KNOXVILLE, TN, Sept. 11, 2019 (GLOBE...
April 17, 2019 08:00 ET | Source: Celsion CORP

Celsion Corporation Announces Issuance of New Patent for ThermoDox®

Represents a Significant Advance for Celsion’s Life Cycle Management Program for ThermoDox® Establishing Bioequivalence Will Extend Market Exclusivity to 2033 LAWRENCEVILLE, N.J,...
February 12, 2019 07:30 ET | Source: Provectus Biopharmaceuticals Inc.

PROVECTUS ANNOUNCES GRANT OF ORPHAN DRUG DESIGNATION IN U.S. TO PV-10 FOR TREATMENT OF OCULAR MELANOMA

KNOXVILLE, TN, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that orphan drug designation (ODD) status was granted by the U.S. Food and Drug Administration (FDA) to small...